The 2nd ICB-PHARMA
It is my great pleasure to welcome you to The 2nd International Current Breakthrough (ICB)-Pharma Symposium 2015 in Solo Indonesia which will be held on October 31st, 2015. This symposium is organised by Faculty of Pharmacy, Universitas Muhammadiyah Surakarta.
ICB-Pharma 2015 features topics on “Current Breakthrough in Pharmacy Material and Analyses”. This is a one full day symposium, consists of morning and afternoon sessions. There will be plenary lectures and session lectures given by several invited speakers from Japan, America as well as from Indonesia, and also selected oral presentations of the submitted papers. The poster session from various fields of pharmaceutical sciences will also take place.
The ICB-Pharma is projected to be a well-known scientific symposium in disseminating the breakthrough and novel technology in pharmacy materials. This purpose can be achieved with encouragement from national and international academic institution partners as well as supports from the industrial partners, Indonesian Pharmacist Association (Ikatan Apoteker Indonesia, IAI) and colleagues. I do hope and believe that, this symposium will offer great opportunities for scientists to meet and discuss recent topics in material and pharmaceutical science and bring the academics, health professionals and industries together for sharing their experiences to solve current problems and challenges in the field.
We are looking forward to see you in Solo-IndonesiaWarm regards,
Azis Saifudin, Ph.D.
Chair of ICB-Pharma Symposium
|Prof. Jackie Y. Ying|
Massachuset Institute of Technology /MIT 1992-2005
Executive Director, Institute of Bioengineering and Nanotechnology, 2003-present
Editor-in-chief Nano Today!
|Asoct. Prof. Takenori Tomohiro|
Graduate School of Medicine and
Pharmaceutical Sciences, University of Toyama, Japan
|Dr. Wangsa Tirta Ismaya
Scientist/Section Head of Recombinant Therapeutic Proteins, Dexa Medica
|"Current breakthrough in nano medicine and nano devices"||"Photoaffinity labeling-based target identification of bioactive molecules"||"Current status of recombinant therapeutic proteins"|